Low-dose thalidomide and donor lymphocyte infusion as adoptive immunotherapy after allogeneic stem cell transplantation in patients with multiple myeloma

被引：0
|
作者：
Kröger, N
Shimoni, A
Zagrivnaja, M
Ayuk, F
Lioznov, M
Schieder, H
Renges, H
Fehse, B
Zabelina, T
Nagler, A
Zander, A
机构：
[1] Zander Univ, Hosp Hamburg, Hamburg, Germany
[2] Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel
来源：
BONE MARROW TRANSPLANTATION | 2005年 / 35卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S47 / S47
页数：1
相关论文
共 50 条
  • [31] Adoptive immunotherapy with donor lymphocyte infusions after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning
    Bethge, WA
    Hegenbart, U
    Stuart, MJ
    Storer, BE
    Maris, MB
    Flowers, MED
    Maloney, DG
    Chauncey, T
    Bruno, B
    Agura, E
    Forman, SJ
    Blume, KG
    Niederwieser, D
    Storb, R
    Sandmaier, BM
    BLOOD, 2004, 103 (03) : 790 - 795
  • [32] Long-Term Results of Prophylactic Donor Lymphocyte Infusions for Patients with Multiple Myeloma after Allogeneic Stem Cell Transplantation
    Groeger, Maximilian
    Gagelmann, Nico
    Wolschke, Christine
    von Pein, Ute-Marie
    Klyuchnikov, Evgeny
    Christopeit, Max
    Zander, Axel
    Ayuk, Francis
    Kroeger, Nicolaus
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (07) : 1399 - 1405
  • [33] Adoptive immunotherapy with donor lymphocyte infusions and interleukin-2 after high-dose therapy and autologous stem cell rescue for multiple myeloma
    Ballester, OF
    Fang, T
    Raptis, A
    Ballester, G
    Wilcox, P
    Hiemenz, J
    Tan, B
    BONE MARROW TRANSPLANTATION, 2004, 34 (05) : 419 - 423
  • [34] Adoptive immunotherapy with donor lymphocyte infusions and interleukin-2 after high-dose therapy and autologous stem cell rescue for multiple myeloma
    O F Ballester
    T Fang
    A Raptis
    G Ballester
    P Wilcox
    J Hiemenz
    B Tan
    Bone Marrow Transplantation, 2004, 34 : 419 - 423
  • [35] Maintenance with low-dose thalidomide after autoSCT in multiple myeloma
    Pezzullo, L
    Rocco, S
    Finizio, O
    Bene, L
    Casale, B
    De Rosa, C
    Mettivier, V
    BONE MARROW TRANSPLANTATION, 2005, 35 : S387 - S387
  • [36] Remarkable activity of novel agents bortezomib and thalidomide in patients not responding to donor lymphocyte infusions following nonmyeloablative allogeneic stem cell transplantation in multiple myeloma
    van de Donk, NWCJ
    Kröger, N
    Hegenbart, U
    Corradini, P
    San Miguel, JF
    Goldschmidt, H
    Perez-Simon, JA
    Zijlmans, M
    Raymakers, RA
    Montefusco, V
    Ayuk, FA
    van Oers, MHJ
    Nagler, A
    Verdonck, LF
    Lokhorst, HM
    BLOOD, 2006, 107 (08) : 3415 - 3416
  • [37] Donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantation
    Roddie, Claire
    Peggs, Karl S.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2011, 11 (04) : 473 - 487
  • [38] Induction of molecular remission by donor lymphocyte infusions in patients with multiple myeloma and residual disease after dose-reduced conditioning and allogeneic stem cell transplantation
    Zagrivnaja, M
    Fehse, B
    Zander, A
    Kröger, N
    BONE MARROW TRANSPLANTATION, 2004, 33 : S326 - S326
  • [39] Maintenance immunotherapy by repetitive low-dose donor lymphocytes infusions in a child with relapse state AML after allogeneic stem cell transplantation
    Hartwig, M.
    Weigel, S.
    Bernig, T.
    Bader, P.
    Doelken, R.
    Beck, J.
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2007, 24 (02) : 137 - 140
  • [40] Prolonged Repeatedly Administered Low Dose Donor Lymphocyte Infusion for Prevention of Relapse After Allogeneic Stem Cell Transplantation for Patients With High Risk Acute Leukemia
    Tsirigotis, Panagiotis
    Stamouli, Maria
    Gkirkas, Konstantinos
    Karagiannidou, Angeliki
    Chondropoulos, Spiros
    Nagler, Arnon
    BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 199 - 200
12345